Go offline with the Player FM app!
Real Brain Technology is Powering Up Drug Discovery and Going Global
Manage episode 518066775 series 3009792
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells.
Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models.
From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to research the treatment of addiction disorders and inking a new agreement with Swiss based InSphero, Tessara Therapeutics is helping to unlock human neuroscience.
Joining us on the MTPConnect podcast is Tessara Therapeutics CEO and Managing Director, Dr Christos Papadimitriou to tell us more about their innovation to accelerate neural drug discovery and their plans to take this technology global.
Chapters
1. Welcome And Acknowledgement to Country (00:00:00)
2. Meet Tessara’s Real Brain Platform (00:00:37)
3. Why Drug Discovery Fails In Neuro (00:04:38)
4. Christos’ Path To Regenerative Neuroscience (00:06:23)
5. Building Scalable, Reproducible Mini-Brains (00:08:08)
6. Human Cells, Donors And Trial Mimics (00:12:44)
7. Customers, FDA Shifts And US Demand (00:14:46)
8. Global Footprint With InSphero (00:18:40)
9. CRC Project On Addiction And Neuroplastigens (00:20:05)
10. Ready-To-Use Plates And AI Roadmap (00:24:14)
11. Made In Parkville And CSIRO Kickstart (00:27:18)
12. Funding Gaps And Australia’s Risk Culture (00:31:14)
13. Talent, Non-Animal Tech Opportunity And Growth (00:34:08)
14. Outro (00:37:36)
203 episodes
Manage episode 518066775 series 3009792
Tessara Therapeutics, a pioneering biotech start-up based in Melbourne, has developed a platform which creates 3D human brain models using stem cells.
Its RealBrain technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain. Ready to accelerate neural drug discovery – without using animal models.
From working with CSIRO’s Kickstart program, receiving a CRC-P grant with Xylo Bio, and the University of Sydney to develop neuroplastogens to research the treatment of addiction disorders and inking a new agreement with Swiss based InSphero, Tessara Therapeutics is helping to unlock human neuroscience.
Joining us on the MTPConnect podcast is Tessara Therapeutics CEO and Managing Director, Dr Christos Papadimitriou to tell us more about their innovation to accelerate neural drug discovery and their plans to take this technology global.
Chapters
1. Welcome And Acknowledgement to Country (00:00:00)
2. Meet Tessara’s Real Brain Platform (00:00:37)
3. Why Drug Discovery Fails In Neuro (00:04:38)
4. Christos’ Path To Regenerative Neuroscience (00:06:23)
5. Building Scalable, Reproducible Mini-Brains (00:08:08)
6. Human Cells, Donors And Trial Mimics (00:12:44)
7. Customers, FDA Shifts And US Demand (00:14:46)
8. Global Footprint With InSphero (00:18:40)
9. CRC Project On Addiction And Neuroplastigens (00:20:05)
10. Ready-To-Use Plates And AI Roadmap (00:24:14)
11. Made In Parkville And CSIRO Kickstart (00:27:18)
12. Funding Gaps And Australia’s Risk Culture (00:31:14)
13. Talent, Non-Animal Tech Opportunity And Growth (00:34:08)
14. Outro (00:37:36)
203 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.